Switch to:

Beam Therapeutics Pre-Tax Income

: $-95.17 Mil (TTM As of Mar. 2020)
View and export this data going back to 2020. Start your Free Trial

Pretax income is the income that a company earns before paying income taxes. Beam Therapeutics's pretax income for the three months ended in Mar. 2020 was $-30.46 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2020 was $-95.17 Mil. Beam Therapeutics's pretax margin was -507,633.33%.

During the past 3 years, Beam Therapeutics's highest Pretax Margin was -396558.33%. The lowest was -435144.44%. And the median was -435144.44%.


Beam Therapeutics Pre-Tax Income Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Beam Therapeutics Annual Data
Dec17 Dec18 Dec19
Pre-Tax Income 0.00 -116.74 -78.33

Beam Therapeutics Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Pre-Tax Income Premium Member Only Premium Member Only -13.61 -17.86 -19.01 -27.85 -30.46

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Beam Therapeutics Pre-Tax Income Distribution

* The bar in red indicates where Beam Therapeutics's Pre-Tax Income falls into.



Beam Therapeutics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Beam Therapeutics's Pretax Income for the fiscal year that ended in Dec. 2019 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-75.154+-5.471+-0.187+2.486+0
=-78.33

Beam Therapeutics's Pretax Income for the quarter that ended in Mar. 2020 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-28.355+-2.7+0+0.597+0
=-30.46

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2020 was -17.861 (Jun. 2019 ) + -19.005 (Sep. 2019 ) + -27.85 (Dec. 2019 ) + -30.458 (Mar. 2020 ) = $-95.17 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Beam Therapeutics  (NAS:BEAM) Pre-Tax Income Explanation

Beam Therapeutics's Pretax Margin for the quarter that ended in Mar. 2020 is calculated as

Pretax Margin=Pretax Income/Revenue
=-30.458/0.006
=-507,633.33%

During the past 3 years, Beam Therapeutics's highest Pretax Margin was -396558.33%. The lowest was -435144.44%. And the median was -435144.44%.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Beam Therapeutics Pre-Tax Income Related Terms


Beam Therapeutics Pre-Tax Income Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)